ClinVar Miner

Submissions for variant NM_000384.3(APOB):c.1853C>T (p.Ala618Val) (rs679899)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
PreventionGenetics,PreventionGenetics RCV000116384 SCV000303934 benign not specified criteria provided, single submitter clinical testing
Cardiovascular Research Group,Instituto Nacional de Saude Doutor Ricardo Jorge RCV000256290 SCV000322835 benign Familial hypercholesterolemia 2016-03-01 criteria provided, single submitter research
Illumina Clinical Services Laboratory,Illumina RCV000295735 SCV000427148 likely benign Familial hypobetalipoproteinemia 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000256290 SCV000427149 likely benign Familial hypercholesterolemia 2016-06-14 criteria provided, single submitter clinical testing
GeneDx RCV000116384 SCV000519196 benign not specified 2016-10-18 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Laboratory of Genetics and Molecular Cardiology,University of São Paulo RCV000256290 SCV000588420 benign Familial hypercholesterolemia 2016-03-01 criteria provided, single submitter research
Color RCV000256290 SCV000687213 benign Familial hypercholesterolemia 2017-06-26 criteria provided, single submitter clinical testing
Color RCV000771026 SCV000902522 benign Familial hypercholesterolemias 2017-07-24 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000116384 SCV000150308 likely benign not specified no assertion criteria provided clinical testing Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.
Pharmacogenomics Lab,Chungbuk National University RCV000845574 SCV000889939 drug response Warfarin response 2010-08-31 no assertion criteria provided research In patients receiving warfarin after mechanical valve replacement, G allele carriers of rs679899 had 6.4 times increased risk of bleeding.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.